» Download Public Reports
About 3 200 reports
- Company report
- April 2013
- 2 pages
... Hexyontm/hexacima complements sanofi pasteur S product family of acp-ipv (acellular pertussis vaccine, inactivated poliovirus vaccine) combination vaccines. The new 6-in-1 vaccine will be available ...
May 2013
... Stribild gilead hiv-1 infection aug. 27 Neutroval sicor biotech neutropenia aug. 29 Linzess forest ibs aug. 30 Xtandi astellas prostate cancer aug. 31 Bosulif pfizer leukemia sep. 4 Aubagio sanofi multiple ...
April 2013
... Equity of access on paper but weak 1010 20/04/2013 harm reduction as a policy pillar is: Rejected by nigeria; Included in 2012-16 drug master plan of so africa but defined as achieved through treatment ...
May 2013
... Production v livestock production v natural resources vdiscuss the roles of government on hiv/aids vdiscuss the roles of pepfar u.S government organization on hiv/aids vdiscuss the impact of hiv/aids ...
May 2013
... Of a polio vaccine what does it take to vaccinate a child against polio This two-minute video from unicef shows us that the journey of a polio vaccine is an incredibly complex process. The menafrivac ctc ...
» Purchase Premium Reports
(From $ 75 - $ 22 781)
About 10 000 reports
- $ 25 515
- Industry report
- February 2013
- by Espicom Business Intelligence
Key Benefits ? Benchmark independent pharmaceutical and healthcare industry forecasts to test other views - a key input for successful budgeting and strategic business planning in the pharmaceutical ...
February 2013
$ 22 022
Espicom market intelligence, brought to you by Business Monitor International The Middle East & Africa Pharmaceuticals & Healthcare Reports feature independent forecasts for drugs and healthcare expenditure ...
February 2013
$ 14 808
Espicom market intelligence, brought to you by Business Monitor International WHY THESE REPORTS ARE IMPORTANT Despite on-going economic pressures, the pharmaceutical industry is one of the most successful ...
May 2013
$ 11 691
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different European countries. The studies provide essential market information ...
May 2013
$ 10 494
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Asian countries. The studies provide essential market information ...
May 2013
$ 7 701
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Eastern European countries. The studies provide essential market ...
February 2013
$ 6 995
PTH(1-31)NH2 (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?PTH(1-31)NH2 (Osteoporosis) - Forecast and Market Analysis ...